» Articles » PMID: 33403792

CT Imaging of Gold Nanoparticles in a Human-sized Phantom

Overview
Date 2021 Jan 6
PMID 33403792
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Gold nanoparticles (AuNPs) are visualized and quantified in a human-sized phantom with a clinical MDCT scanner.

Methods: Experiments were conducted with AuNPs between 0.00171 and 200 mgAu/mL. CT images were acquired at 80, 100, 120, and 140 kVp in a 33-cm phantom. Image contrast due to AuNPs was experimentally determined from regions of interest (ROIs) and effective linear attenuation coefficients were calculated from CT x-ray spectra with consideration of tissue attenuation.

Results: The typical 12-bit dynamic range of CT images was exceeded for AuNPs at 150 mgAu/mL. A threshold concentration of 0.3-1.4 mgAu/mL was determined for human visualization in 1-mm images at a typical diagnostic CTDI of 23.6 mGy. Optimal image contrast was also achieved at 120 kVp and verified by calculation.

Conclusions: We have shown that scanners capable of reconstructing images with extended Hounsfield scales are required for distinguishing any contrast differences above 150 mgAu/mL. We have also shown that AuNPs result in optimal image contrast at 120 kVp in a human-sized phantom due to gold's 80.7 keV k-edge and the attenuation of x-rays by tissue. Typical CT contrast agents, like iodine, require the use of lower kVps for optimal visualization, but lower kVps are more difficult to implement in the clinic because of elevated noise levels, elongated scan times, and/or beam-hardening artifacts. This indicates another significant advantage of AuNPs over iodine not yet discussed in the literature.

Citing Articles

New Opportunities and Old Challenges in the Clinical translation of Nanotheranostics.

Gawne P, Ferreira M, Papaluca M, Grimm J, Decuzzi P Nat Rev Mater. 2024; 8(12):783-798.

PMID: 39022623 PMC: 11251001. DOI: 10.1038/s41578-023-00581-x.


Image contrast assessment of metal-based nanoparticles as applications for image-guided radiation therapy.

Nakayama M, Akasaka H, Miyazaki E, Goto Y, Oki Y, Kawate Y Phys Imaging Radiat Oncol. 2021; 20:94-97.

PMID: 34869923 PMC: 8626564. DOI: 10.1016/j.phro.2021.11.003.

References
1.
Kim D, Park S, Lee J, Jeong Y, Jon S . Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. J Am Chem Soc. 2007; 129(24):7661-5. DOI: 10.1021/ja071471p. View

2.
Beik J, Jafariyan M, Montazerabadi A, Ghadimi-Daresajini A, Tarighi P, Mahmoudabadi A . The benefits of folic acid-modified gold nanoparticles in CT-based molecular imaging: radiation dose reduction and image contrast enhancement. Artif Cells Nanomed Biotechnol. 2017; 46(8):1993-2001. DOI: 10.1080/21691401.2017.1408019. View

3.
Ashton J, Castle K, Qi Y, Kirsch D, West J, Badea C . Dual-Energy CT Imaging of Tumor Liposome Delivery After Gold Nanoparticle-Augmented Radiation Therapy. Theranostics. 2018; 8(7):1782-1797. PMC: 5858500. DOI: 10.7150/thno.22621. View

4.
Sun I, Eun D, Na J, Lee S, Kim I, Youn I . Heparin-coated gold nanoparticles for liver-specific CT imaging. Chemistry. 2009; 15(48):13341-7. DOI: 10.1002/chem.200902344. View

5.
Shilo M, Reuveni T, Motiei M, Popovtzer R . Nanoparticles as computed tomography contrast agents: current status and future perspectives. Nanomedicine (Lond). 2012; 7(2):257-69. DOI: 10.2217/nnm.11.190. View